medigraphic.com
Asociación Mexicana de Gastroenterología

2005, Number 3

<< Back Next >>

Rev Gastroenterol Mex 2005; 70 (3)

Comparative study of propranolol versus propranolol plus isosorbide 5-mononitrate in portal hypertension in cirrhotics. Evaluating splanchnic hemodynamics with color Doppler ultrasound

Sánchez DJ, Ramos GMV, Velazquez OE

Language: Spanish
References: 17
Page: 261-268
PDF size: 58.90 Kb.


ABSTRACT

Background: Hemorragic portal hypertension (HTP-H) has a mortality of 30-40%. Propranolol alone or in combination with isosorbide-5-mononitrate (5MNI) has been wed as hemorrhage preventive treatment. Objective: Compare propranolol vs. propranolol and 5MNI as preventive treatment of HTP-H, evaluating splachnic hemodynamics by color Doppler ultrasound (EDC). Methodology: We included 20 patients with liver cirrhosis, mean age 53.3 years, 13 female, 10 for primary prevention and assigned them in to 2 groups treatment: l.- Propranolol alone (10 patients), ll.- Propranolol + 5-MNI (10 patients). We carried out EDC to each patient before iniciating and 2 months after treatment. Results: A decrease in splachnic hemodynamics was found in both groups as measured by portal vein (PV), hepatic artery (HA) velocity and flux decreased in group I were: PV velocity from 15.4 to 12.5 cm/seg (p = 0.019089 ) and flux from 1639.8 to 1396.8 mL/min (p = 0.031082), HA velocity from 50.1 to 44.5 cm/seg (p = 0.120385 ), and flux 547.1 a 470 mL/min (p = 0.069642); in group ll: PV from 16.6 to 12.9 (p = 0.019699) and from 1,786.8 to 1,304.2 (p = 0.004072), in HA from 52.3 to 44.4 (p = 0.003498 ) and 612.5 to 448.8 (p = 0.000285). Conclusion: Propranolol and 5-MNI decreases splachnic flux and velocity more than propranolol alone, in consequence it should be better to prevent bleeding from portal hypertension.


REFERENCES

  1. Lewis R, et al. Pathophysiology and treatment of variceal hemorrhage. Mayo Clin Proc 1996; 71(10): 973-83.

  2. Burroughs A, et al. Pharmacological treatment of acute variceal bleeding. Digestion 1998; 59(Suppl. 2): 28-36.

  3. D´Amico G, et al. The treatment of portal hypertension: a meta-analytical review. Hepatology 1995; 22: 332-54.

  4. North Italian Endoscopic Club For The Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1998; 319: 985-9.

  5. Lawrence S, et al. Gastroesophageal varices: prevention of bleeding and rebleeding. Gastroenterol Clin N Am 1993; 22(4): 801-19.

  6. Pagliaro L, et al. Therapeutic controversies and randomized controlled trial 8RCTs: prevention of bleeding and rebleeding in cirrhosis. Gastroenterol Intern 1998; 2: 71-84.

  7. Angelico M, et al. Effects of Isosorbide-5-mononitrate compared with propranolol on first-bleeding and long-term survival in cirrhosis. Gastroenterology 1997; 113: 1632-9.

  8. Escorsell A, et al. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic heamodynamics in patients with cirrhosis. J Hepatol 1996; 24: 423-9.

  9. North Italian Endoscopic Club For The Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1998; 319: 985-9.

  10. Lebrec D, et al. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology 1984; 4: 355-8.

  11. Escorcell A, et al. The portal pressure response to b-blockade is greater in cirrhotic patients without varices than in those with varices. Gastroenterology 1997; 112: 2012-16.

  12. Garcia PJ, et al. Enhancement of portal pressure reduction by the association of isosorbide 5-mononitrate to propranolol administration in patients with cirrhosis. Hepatology 1990; 11: 230-8.

  13. Pascal J, et al. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage-in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1987; 317: 856-61.

  14. Merkel C, et al. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate nadolol in cirrhotic patients with insufficient response to the b-blocker alone. Hepatology 1997; 26: 34-9.

  15. Zoli M, et al. Transdermal nitroglycerin in cirrhosis. A 24-hour echo-Doppler study of splanchnic hemodynamics. J Hepatology 1996; 25: 498-503.

  16. Albillos A, et al. Propranolol plus Prazosin compared with propranolol plus isosorbide-5-mono-nitrate in the treatment of portal hypertension. Gastroenterology 1998; 115: 116-23.

  17. Poo JL y cols. El propranolol previene la primera hemorragia variceal en pacientes cirróticos mexicanos con várices esofágicas: estudio prospectivo controlado, con asignación aleatoria. Rev Gastroenterol Mex 1993; 58: 339.




2020     |     www.medigraphic.com